DanielPaulFerranteDO

Obstetrics and Gynecology Department Chairman, High-Risk Pre-natal Clinic Medical Director, Medical Executive Committee Member at Saint Clare's Health, member of Prime Healthcare, Member of the Board Clinical Governance, Lifeline Medical Associates

Join to view full profile

Dr. Ferrante is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ferrante's full profile

Already have an account?

Office
16 Pocono Park
Suite 217
Denville, NJ 07834
Phone+1 973-784-3935

Summary

I am a board certified obstetrician gynecologist with 33 years experience specializing in obstetrics, gynecology, gynecologic surgery and minimally invasive surgery. I am published in contraception research and most recently genetic screening protocols for Myriad Genetics. I continue to speak nationally on long term contraception, umbilical cord stem cell collection and genetic testing for gene mutations related to increased cancer risk. I am currently Chairman of the department of Obstetrics and Gynecology at Prime Healthcare, Saint Clare's health, N.J. and a member of the Board of Clinical Governance of Lifeline Medical associates. I am also a founding member of Lifeline Medical Associates, Unified Women's Health; now 155 single specialty providers, in New Jersey since 1997.

Education & Training

Christiana Care Health ServicesResidency, Obstetrics and Gynecology, 1987 - 1991
Rowan University School of Osteopathic MedicineClass of 1987

Certifications & Licensure

NJ State License 1989 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

Journal Articles

Genetic cancer risk assessment by Women's Health Providers: Resource Solutions to Support Identification and Appropriate Testing
Daniel Ferrante DO, Poster, 9/10/2024
Compliance and insertion training Mirena levonorgestrel iud , United States multicenter trial.
Daniel Ferrante DO principle investigator, Fertility, 1/17/1998

Lectures

Long term reversible contraception with levonorgestrel iud Liletta.
Washington D.C ACOG National Meeting - 5/5/2013
Levonorgestrel iud, long term analysis and use
Red Bank, NJ District 3 ACOG annual meeting - 6/15/2005

Committees

Member as Chairman of Department of Obstetrics and Gynecology, Medical Executive Committee, Saint Clare's Health 2019 - Present

Research History

Principle investigatorGenetic Cancer risk assessment by Women's Health Providers: Resources Solutions to Support Identification and Appropriate Testing2022 - 2023
Principle InvestigatorMulticenter trial of new oral contraceptive.
Principle InvestigatorA multicenter, Open-Label, Uncontrolled Trial with Levonorgestrel releasing Intrauterine System to evaluate the Insertion and Counseling Procedures Clinical Study Phase IIIB